These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25927974)

  • 1. Transcriptional implications of intragenic DNA methylation in the oestrogen receptor alpha gene in breast cancer cells and tissues.
    Shenker NS; Flower KJ; Wilhelm-Benartzi CS; Dai W; Bell E; Gore E; El Bahrawy M; Weaver G; Brown R; Flanagan JM
    BMC Cancer; 2015 May; 15():337. PubMed ID: 25927974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer.
    Ramos EA; Camargo AA; Braun K; Slowik R; Cavalli IJ; Ribeiro EM; Pedrosa Fde O; de Souza EM; Costa FF; Klassen G
    BMC Cancer; 2010 Jan; 10():23. PubMed ID: 20109227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients.
    Martínez-Galán J; Torres-Torres B; Núñez MI; López-Peñalver J; Del Moral R; Ruiz De Almodóvar JM; Menjón S; Concha A; Chamorro C; Ríos S; Delgado JR
    BMC Cancer; 2014 Feb; 14():59. PubMed ID: 24495356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-Specific Expression of Estrogen Receptor 1 Is Regulated by DNA Methylation in a T-DMR.
    Maekawa R; Sato S; Okada M; Lee L; Tamura I; Jozaki K; Kajimura T; Asada H; Yamagata Y; Tamura H; Yamamoto S; Sugino N
    Mol Endocrinol; 2016 Mar; 30(3):335-47. PubMed ID: 26683811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of the CpG methylation status of ER alpha gene in estrogen receptor alpha-negative breast cancer cell lines and the role of hydralazine demethylation].
    Tang B; Jiang J
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):283-7. PubMed ID: 16181550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
    Ramezani F; Salami S; Omrani MD; Maleki D
    Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Changes of the ESR1 Gene in Breast Tissue of Healthy Women: A Missing Link with Breast Cancer Risk Factors?
    Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Younosi N; Meysamie A; Mansoori Y; Bastami M; Tavakkoly-Bazzaz J
    Genet Test Mol Biomarkers; 2017 Aug; 21(8):464-470. PubMed ID: 28708432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESR1-promoter-methylation status in primary breast cancer and its corresponding metastases.
    Kirn V; Strake L; Thangarajah F; Richters L; Eischeid H; Koitzsch U; Odenthal M; Fries J
    Clin Exp Metastasis; 2018 Oct; 35(7):707-712. PubMed ID: 30173322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESR1 and PGR gene promoter methylation and correlations with estrogen and progesterone receptors in ductal and lobular breast cancer.
    Medina-Jaime AD; Reyes-Vargas F; Martinez-Gaytan V; Zambrano-Galvan G; Portillo-Delcampo E; Burciaga-Nava JA; Reyes-Romero M; Sifuentes-Alvarez A
    Asian Pac J Cancer Prev; 2014; 15(7):3041-4. PubMed ID: 24815444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer.
    Stone A; Zotenko E; Locke WJ; Korbie D; Millar EK; Pidsley R; Stirzaker C; Graham P; Trau M; Musgrove EA; Nicholson RI; Gee JM; Clark SJ
    Nat Commun; 2015 Jul; 6():7758. PubMed ID: 26169690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer.
    Muggerud AA; Rønneberg JA; Wärnberg F; Botling J; Busato F; Jovanovic J; Solvang H; Bukholm I; Børresen-Dale AL; Kristensen VN; Sørlie T; Tost J
    Breast Cancer Res; 2010; 12(1):R3. PubMed ID: 20056007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 Binds to estrogen receptor 1 promoter in human breast cancer cells.
    Rasti M; Arabsolghar R; Khatooni Z; Mostafavi-Pour Z
    Pathol Oncol Res; 2012 Apr; 18(2):169-75. PubMed ID: 21655924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epigenetic silencing of the estrogen receptor (ER) by hypermethylation of the ESR1 promoter is seen predominantly in triple-negative breast cancers in Indian women.
    Prabhu JS; Wahi K; Korlimarla A; Correa M; Manjunath S; Raman N; Srinath BS; Sridhar TS
    Tumour Biol; 2012 Apr; 33(2):315-23. PubMed ID: 22362381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic mechanisms regulate the prostaglandin E receptor 2 in breast cancer.
    To SQ; Takagi K; Miki Y; Suzuki K; Abe E; Yang Y; Sasano H; Simpson ER; Knower KC; Clyne CD
    J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):331-8. PubMed ID: 22929011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1.
    Dunbier AK; Anderson H; Ghazoui Z; Lopez-Knowles E; Pancholi S; Ribas R; Drury S; Sidhu K; Leary A; Martin LA; Dowsett M
    PLoS Genet; 2011 Apr; 7(4):e1001382. PubMed ID: 21552322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation.
    Rauscher GH; Kresovich JK; Poulin M; Yan L; Macias V; Mahmoud AM; Al-Alem U; Kajdacsy-Balla A; Wiley EL; Tonetti D; Ehrlich M
    BMC Cancer; 2015 Oct; 15():816. PubMed ID: 26510686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of protein expression and DNA methylation profiles detected by pyrosequencing in invasive breast cancer.
    Zmetakova I; Danihel L; Smolkova B; Mego M; Kajabova V; Krivulcik T; Rusnak I; Rychly B; Danis D; Repiska V; Blasko P; Karaba M; Benca J; Pechan J; Fridrichova I
    Neoplasma; 2013; 60(6):635-46. PubMed ID: 23906298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.
    Borges S; Döppler H; Perez EA; Andorfer CA; Sun Z; Anastasiadis PZ; Thompson E; Geiger XJ; Storz P
    Breast Cancer Res; 2013 Aug; 15(2):R66. PubMed ID: 23971832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant p53 binds to estrogen receptor negative promoter via DNMT1 and HDAC1 in MDA-MB-468 breast cancer cells.
    Arabsolghar R; Azimi T; Rasti M
    Mol Biol Rep; 2013 Mar; 40(3):2617-25. PubMed ID: 23242655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of estrogen receptor-1 mutation in advanced breast cancer: The estrogen receptor one study (EROS1).
    Najim O; Huizing M; Papadimitriou K; Trinh XB; Pauwels P; Goethals S; Zwaenepoel K; Peterson K; Weyler J; Altintas S; van Dam P; Tjalma W
    Cancer Treat Res Commun; 2019; 19():100123. PubMed ID: 30826563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.